Výsledky vyhledávání - "Mónica Esther Rosenberg"

Bioequivalence Study of 2 Capsule Formulations of Fingolimod 0.5 mg Assessing Both Parent Drug and Active Metabolite in New Zealand Healthy Subjects (Truncated Design)

Autor: Fernando Guillermo Costa, Mónica Esther Rosenberg, Cheung-Tak Hung, Noelyn Anne Hung

Publikováno v: Clinical Pharmacology in Drug Development. 9:610-620

Fingolimod is indicated for the treatment of patients with the relapsing-remitting form of multiple sclerosis. The primary study objective was to evaluate the bioequivalence of a test formulation, 0.5 mg fingolimod HCl capsule (Lebrina, Asofarma Soci

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::342f953c2647b7564a48e5f220b567c6
https://doi.org/10.1002/cpdd.813

Zobrazit plný text záznamu

Plný text ve formátu HTML

A Randomized, Open-Label, Two-Way Crossover, Single-Dose Bioequivalence Study of Temozolomide 200 mg/m2 (Dralitem® vs. Temodal® Capsules) in Patients with Primary Tumors of the Central Nervous System Under Fasting Conditions

Autor: Miguel Vago, Cecilia González, Cristian Magariños, Fernando Guillermo Costa, Marcelo Rubio, Alejandro Muggeri, Santiago Pérez-Lloret, Mónica Esther Rosenberg, Sebastián Ezequiel Pérez

Publikováno v: Drugs in R&D. 17:427-434

Temozolomide is an antineoplastic agent of proven efficacy against high-grade gliomas. The objective of this crossover, single-dose, bioequivalence study was to compare the rate and extent of absorption of oral temozolomide after administration of th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a4c2aa4d2fe41503708dc64c28368eaf
https://doi.org/10.1007/s40268-017-0199-3

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání